Evonetix

Developer of synthetic biology platform

placeSaffron Walden, England, United Kingdom calendar_todayFounded 2015 groups49 employees language evonetix.com

Registered entities

Innovation

14 patent families (9 granted) — focus: Chemistry & metallurgy, Operations & transport, Physics & computing, Mechanical engineering; filing pace slowing. Cited 576 times.

YearFilings
20162
20175
20188
20195
20206
20216
20226
20237
20249
20252

Investor mix

28 investors on record; lead investors include DCVC, Draper Esprit, Foresite Capital.

Investor typeCountShare
Venture capital1243%
Private equity14%
Other / undisclosed1554%
Coming soon